Licoisoflavone A

CAS No. 66056-19-7

Licoisoflavone A( Phaseoluteone )

Catalog No. M29182 CAS No. 66056-19-7

Licoisoflavone A is a potential MRP inhibitor, it shows inhibitory effects on copper-induced protein oxidative modification of mice brain homogenate in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 286 Get Quote
10MG 428 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Licoisoflavone A
  • Note
    Research use only, not for human use.
  • Brief Description
    Licoisoflavone A is a potential MRP inhibitor, it shows inhibitory effects on copper-induced protein oxidative modification of mice brain homogenate in vitro.
  • Description
    Licoisoflavone A is a potential MRP inhibitor, it shows inhibitory effects on copper-induced protein oxidative modification of mice brain homogenate in vitro.(In Vitro):Licoisoflavone A inhibits copper-induced protein oxidative modification of mice brain homogenate in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Phaseoluteone
  • Pathway
    Endocrinology/Hormones
  • Target
    MRP
  • Recptor
    MRP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66056-19-7
  • Formula Weight
    354.358
  • Molecular Formula
    C20H18O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (282.21 mM)
  • SMILES
    CC(C)=CCc1c(O)ccc(c1O)-c1coc2cc(O)cc(O)c2c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Benzocaine

    Benzocaine is a surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.

  • Cholesterol

    Cholesterol is the major sterol in mammals, and its importance in fundamental cellular processes is becoming more appreciated.

  • Propafenone

    An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.